biotech

Showing 15 posts of 861 posts found.

georgescangos

Vir Biotech blasts out of the blocks, with $500m in bank

October 19, 2017
Medical Communications, Sales and Marketing Vir Biotechnology, biotech, drugs, pharma, pharmaceutical

All has been quiet since former Biogen CEO, George Scangos, departed the company and then set up Vir Biotechnology in …

gilead-sciences

Gilead gets FDA nod for revolutionary blood cancer treatment

October 19, 2017
Sales and Marketing CAR-T, Gilead, Yescarta, biotech, drugs, pharma, pharmaceutical

Only weeks after Gilead announced the completion of Kite, it got the news it was hoping for with the FDA’s …

mit-ai-cancer-detection-01_0

Breakthrough AI able to identify 97% of breast cancer risk

October 18, 2017
Research and Development MIT, biotech, breast cancer, drugs, pharma, pharmaceutical

 Scientists at MIT’s Computer Science and Artificial Intelligence Laboratory have developed a machine learning AI system that is able diagnose …

nhs_trees

New studies point to cracks forming in NHS services

October 18, 2017
Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical

Two studies published separately by the BBC and the Care Quality Commission (CQC) point to growing problems across NHS services …

J&J’s third quarter: The good and the bad

October 18, 2017
Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Janssen, Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

It was a mixed bag for Johnson & Johnson on its announcement of third quarter results. It could largely be …

Allergan’s patent shield – The (Native) American dream?

October 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

  In an unprecedented move, leading global pharmaceutical company Allergan appears to have handed its Orange Book-listed US patents covering …

peanuts

Peanut allergies? There’s a clinical trial looking to fix that

October 17, 2017
Manufacturing and Production, Research and Development Aimmune, Regeneron, Sanofi, biotech, drugs, peanuts, pharma, pharmaceutical

Aimmune Therapeutics, a biotech company developing treatments for food allergies, announced that it has entered into a clinical trial collaboration …

EMA responds to criticism of its cancer drug approvals

October 17, 2017
Manufacturing and Production, Medical Communications Cancer, EMA, biotech, drugs, oncology, pharma, pharmaceutical

The EMA received a broadside just less than two week ago from a group of researchers that had studied data …

5440392565_4634fb9d24_z

Trump suggests he will declare opioid national emergency next week

October 17, 2017
Manufacturing and Production, Sales and Marketing President trump, Trump, biotech, drugs, pharma, pharmaceutical

Back in August, President Trump had suggested that the opioid epidemic that is ravaging the US would be declared a …

veeva

Simplify your regulatory processes

October 16, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, veeva

It’s always crunch time for regulatory operations. Whether you’re managing plans and documents for an upcoming IND or producing routine product variations, …

prevail_-_ebola_vaccination

Trials reveal two strong vaccine candidates for Ebola

October 16, 2017
Research and Development, Sales and Marketing Ebola, biotech, drugs, pharma, pharmaceutical

Two clinical-stage vaccine candidates for Ebola have produced stunning results, not least because an unexpected protection emerged. The two therapies …

roche__tree

Roche launches Warp Drive antibiotic collaboration for $387m

October 16, 2017
Sales and Marketing Antibiotics, Roche, biotech, drugs, pharma, pharmaceutical

Roche had tentatively begun to re-enter the antibiotic space, but it has now signalled its growing intention to move in …

nerves

Breakthrough study could revolutionise MS treatment

October 13, 2017
Medical Communications, Research and Development biotech, drugs, multiple sclerosis, pharma, pharmaceutical

The results of a study from the University of California, San Francisco will be welcomed with a certain excitement from …

news

Free Webinar: EudraVigilance changes and the impact on MAHs

October 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, eudravigilance, pharma, pharmaceutical, primevigilance

Following on from the popularity of our previous free webinar sessions, Pharmafocus is once again partnering with PrimeVigilance to bring you an overview of the EudraVigilance changes and their impact on MAHs.

microscope-275984_960_720

First leprosy vaccine makes initial step towards human use

October 13, 2017
Medical Communications, Research and Development biotech, drugs, leprosy, pharma, pharmaceutical

A vaccine for leprosy, developed by the Infectious Disease Research Institute (IDRI) and with the financial support of the American …

The Gateway to Local Adoption Series

Latest content